Does INTERFERON BETA-1A Cause Product dose omission issue? 601 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 601 reports of Product dose omission issue have been filed in association with INTERFERON BETA-1A (Avonex). This represents 0.9% of all adverse event reports for INTERFERON BETA-1A.
601
Reports of Product dose omission issue with INTERFERON BETA-1A
0.9%
of all INTERFERON BETA-1A reports
1
Deaths
129
Hospitalizations
How Dangerous Is Product dose omission issue From INTERFERON BETA-1A?
Of the 601 reports, 1 (0.2%) resulted in death, 129 (21.5%) required hospitalization, and 4 (0.7%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1A. However, 601 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA-1A Cause?
Multiple sclerosis relapse (5,931)
Influenza like illness (4,475)
Memory impairment (3,468)
Multiple sclerosis (3,412)
Fatigue (3,164)
Fall (3,128)
Gait disturbance (3,031)
Death (2,766)
Pain (2,692)
Headache (2,533)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which INTERFERON BETA-1A Alternatives Have Lower Product dose omission issue Risk?
INTERFERON BETA-1A vs INTERFERON BETA-1B
INTERFERON BETA-1A vs INTERFERON GAMMA
INTERFERON BETA-1A vs INTERFERON GAMMA-1B
INTERFERON BETA-1A vs INVEGA
INTERFERON BETA-1A vs INVEGA SUSTENNA